Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 3Resistance Training 2Megestrol Acetate 2Educational Status 2semaglutide 1naldemedine 1mirabegron 1ma zi ren wan 1exemestane 1Weights and Measures 1Transcutaneous Electric Nerve Stimulation 1Tablets 1Stents 1Standard of Care 1Spermine Synthase 1Specimen Handling 1Psychiatric Rehabilitation 1Progestins 1Practice Guidelines as Topic 1Nutrition Assessment 1Methods 1Metformin 1Medroxyprogesterone Acetate 1Massage 1Magnetic Resonance Spectroscopy 1Leuprolide 1Letrozole 1Interviews as Topic 1Hysteroscopy 1Hypnosis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Estrogen Replacement Therapy × Other × 30 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡